Oncology Archives - Page 20 of 23

Medical Resource Utilization and Costs from Subsequent Metastasis in Prostate Cancer (PC) Patients Initially Diagnosed with Locoregional Disease

Authors: Li, Shore N.; Mehra, M.; Todd, M.; Saadi. R.; Leblay, G.; Griffiths, R.; Aggarwal, J. Published: ASCO, 2016 View publication Background In prostate cancer (PC), progression from locoregional to metastatic disease...

Cost analysis for different sequential treatment regimens for metastatic renal cell carcinoma in China

Authors: G Shi, S H Park, H Ren, M Xue, X Lu, P Dong, X Gao Published: Journal of Medical Economics, 2018 View publication Purpose Targeted therapies including sunitinib, sorafenib, axitinib, and...

Quality-adjusted survival with nab-paclitaxel versus standard paclitaxel in metastatic breast cancer: a Q-TWiST analysis

Authors: J Cortes, J Perez-Garcia, S Whiting, Y Wan, C Solem, M H Tai, S Margunato-Debay, A Ko, A Fandi, M Botteman Published: Clinical Breast Cancer, 2018 View publication Background In this...

Quality-adjusted outcomes stratified by response in patients with advanced non-small-cell lung cancer receiving first-line nab-paclitaxel/carboplatin or paclitaxel/carboplatin

Authors: V Hirsh, Y Wan, F J Lin, S Marqunato-Debay, T J Ong, M Botteman, C Langer Published: Clinical Lung Cancer, 2018 View publication Background First-line nab-paclitaxel/carboplatin was associated with a significantly...

Patient-reported treatment-related symptom burden for patients with advanced melanoma in Canada

Authors: WY Cheung; MK White; MS Bayliss; A Stroupe; A Lovley; BL King-Kallimanis; K Lasch Published: Support Care Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer, 2018 View...

Nab-paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: Australian subset analyses of the phase III MPACT trial

Authors: R Young, P Mainwaring, P Clingan, FX Parnis, G Asghari, P Beale, A Aly, M Botteman, A Romano, S Ferrara, S Margunato-Debay, M Harris Published: Asia-Pacific Journal of Clinical Oncology, 2018...

Performance status dynamics during treatment with nab-paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancer

Authors: E G Chiorean, D Von Hoff, Y Wan, S Margunato-Debay, M Botteman, D Goldstein Published: Cancer Management and Research, 2018 View publication Objectives This analysis examined changes in Karnofsky performance status...

Cost effectiveness of bisphosphonates in the management of breast cancer patients with bone metastases

Authors: M Botteman, V Barghout, J Stephens, J Hay, J Brandman, M Aapro Published: Annals of Oncology, 2010 View publication Background Bisphosphonates are recommended to prevent skeletal related events (SREs) in patients...

Economic evaluation of zoledronic acid for the prevention of osteoporotic fractures in postmenopausal women with early-stage breast cancer receiving aromatase inhibitors in the UK

Authors: J F Logman, B M Heeg, M F Botteman, S Kaura, B A van Hout Published: Annals of Oncology, 2010 View publication Background Aromatase inhibitors are used as adjuvant therapy for...

News